Marie‐Lorraine Chrétien

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre et al. · Blood · 2018 · 420 citations · Full text

Medicine, Hematology, Oncology +15

Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome

Murielle Roussel, Valérie Lauwers‐Cancès, Nelly Robillard et al. · Journal of Clinical Oncology · 2014 · 265 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment

Kyohei Nakamura, Sahar Kassem, Alice Cleynen et al. · Cancer Cell · 2018 · 221 citations · Full text

Medicine, Immunology, Oncology +15

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Elodie Tournay et al. · Journal of Clinical Oncology · 2019 · 179 citations · Full text

Medicine, Hematology, Oncology +16

The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?

C. Legouge, Denis Caillot, Marie‐Lorraine Chrétien et al. · Clinical Infectious Diseases · 2013 · 170 citations

Medicine, Infectious Diseases, Oncology +15